Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

294 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
Williams NL, Wuthrick EJ, Kim H, Palmer JD, Garg S, Eldredge-Hindy H, Daskalakis C, Feeney KJ, Mastrangelo MJ, Kim LJ, Sato T, Kendra KL, Olencki T, Liebner DA, Farrell CJ, Evans JJ, Judy KD, Andrews DW, Dicker AP, Werner-Wasik M, Shi W. Williams NL, et al. Among authors: andrews dw. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):22-30. doi: 10.1016/j.ijrobp.2017.05.028. Epub 2017 May 26. Int J Radiat Oncol Biol Phys. 2017. PMID: 28816150 Clinical Trial.
Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1-3 brain metastases; poststratified by the graded prognostic assessment (GPA).
Sperduto PW, Shanley R, Luo X, Andrews D, Werner-Wasik M, Valicenti R, Bahary JP, Souhami L, Won M, Mehta M. Sperduto PW, et al. Int J Radiat Oncol Biol Phys. 2014 Nov 1;90(3):526-31. doi: 10.1016/j.ijrobp.2014.07.002. Epub 2014 Sep 26. Int J Radiat Oncol Biol Phys. 2014. PMID: 25304947 Free PMC article. Clinical Trial.
A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas.
Den RB, Kamrava M, Sheng Z, Werner-Wasik M, Dougherty E, Marinucchi M, Lawrence YR, Hegarty S, Hyslop T, Andrews DW, Glass J, Friedman DP, Green MR, Camphausen K, Dicker AP. Den RB, et al. Among authors: andrews dw. Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):321-8. doi: 10.1016/j.ijrobp.2012.04.017. Epub 2012 Jun 9. Int J Radiat Oncol Biol Phys. 2013. PMID: 22687197 Free PMC article. Clinical Trial.
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial.
Shi W, Lawrence YR, Choy H, Werner-Wasik M, Andrews DW, Evans JJ, Judy KD, Farrell CJ, Moshel Y, Berger AC, Bar-Ad V, Dicker AP. Shi W, et al. Among authors: andrews dw. J Neurooncol. 2014 Jun;118(2):313-319. doi: 10.1007/s11060-014-1433-2. Epub 2014 Apr 13. J Neurooncol. 2014. PMID: 24728831 Clinical Trial.
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.
Wuthrick EJ, Curran WJ Jr, Camphausen K, Lin A, Glass J, Evans J, Andrews DW, Axelrod R, Shi W, Werner-Wasik M, Haacke EM, Hillman GG, Dicker AP. Wuthrick EJ, et al. Among authors: andrews dw. Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):369-75. doi: 10.1016/j.ijrobp.2014.05.034. Epub 2014 Aug 4. Int J Radiat Oncol Biol Phys. 2014. PMID: 25104067 Free PMC article.
294 results